You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大理藥業(603963.SH):公司整條生產線將按計劃分工序陸續停產更換壓力容器設備
格隆匯 09-10 17:08

格隆匯 9 月 10日丨大理藥業(603963.SH)公佈,公司2號提取車間用於醒腦靜注射參麥注射液亮菌甲素注射液中間產品生產壓力容器設備於2012年安裝使用至今,現已達到設計使用年限,根據國家《特種設備安全監察條例》相關應當及時予以報廢並更換,為此近日公司整條生產線將按計劃分工序陸續產更換壓力容器設備

公司主營業務系中、西藥注射劑的生產和銷售,主要產品為“中精牌”醒腦靜注射液、參麥注射液亮菌甲素注射液上述產品2019年實現主營業務收入2.94營業收入99.9%本次計劃停產時間為50-60天。

為確保停產期間市場供貨不受影響,本次停公司已按銷售計划進行了備貨準備,現各品種規格產品庫存量可以充分滿足停產客户需求。為此本次不會對公司銷售產生不利影響,公司將會抓緊壓力容器設備安裝、調試工作儘快恢復生產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account